Cigna Group $CI Shares Sold by JFS Wealth Advisors LLC

JFS Wealth Advisors LLC lessened its holdings in shares of Cigna Group (NYSE:CI) by 6.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 636 shares of the health services provider’s stock after selling 44 shares during the quarter. JFS Wealth Advisors LLC’s holdings in Cigna Group were worth $210,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of CI. Valeo Financial Advisors LLC grew its stake in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Nuveen LLC acquired a new stake in Cigna Group during the 1st quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD grew its stake in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares in the last quarter. GQG Partners LLC grew its stake in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on CI shares. Barclays increased their target price on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a report on Thursday, June 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday. Wells Fargo & Company increased their target price on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a report on Tuesday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $372.69.

Cigna Group Trading Down 1.7%

Shares of NYSE CI opened at $301.00 on Friday. The company has a market cap of $80.35 billion, a price-to-earnings ratio of 16.43, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock’s 50 day simple moving average is $294.68 and its 200 day simple moving average is $309.23.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.